Across the innovative therapy landscape, regulators and payers are constantly assessing the cost effectiveness of new therapies. In this issue, we highlight the importance of capturing and demonstrating value of the therapy throughout the product development lifecycle to support approval and reimbursement decisions.
HEOR-centric Gene Therapy Development
Stay In Touch with SSI
Our goal is to provide useful and poignant content at a few key points throughout the year. If you would like to see an example of the type of information we share, view our most recent issue of Wavelengths.